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Telomere and Telomerase: brief review of a history initiated by
Hermann Müller and Barbara McClintock
LILIAN CHUAIRE. M.SC.*
SUMMARY
What is the nature of the biological clock that determines the cells aging? What is the way to explain the genesis of diseases
associated in aging? The above are only some of the questions whose answer could be found within the modus operandi frame
of the telomere-telomerase pair, which had become in objective of study for a number of science men and women since the pioneers
Hermann Müller and Barbara McClintock, until the most recent Jack Szostak, Elizabeth Blackburn and Carol Greider, among others.
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RESUMEN
¿Cuál es la naturaleza del reloj biológico que determina el envejecimiento de las células? ¿De qué manera se explica la génesis
de las enfermedades asociadas con el envejecimiento? Las anteriores son sólo algunas de las preguntas cuya respuesta puede ser
hallada en el marco del modus operandi de la dupla telómeros-telomerasa, convertida en objeto de estudio para un sinnúmero de
hombres y mujeres de ciencia, desde los pioneros Hermann Müller y Bárbara McClintock hasta los más recientes Jack Szostak,
Elizabeth Blackburn y Carol Greider, entre otros.
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In 1938, when the young North American geneticist
Hermann J. Müller used to work with flies of the species
Drosophila melanogaster, exposed to X rays at the
Edinburgh Animal Genetics Institute (United Kingdom),
he did not foresee the implications that his findings would
have in the molecular biology and genetics in the following
70 years. He had just observed that the ends of the
irradiated chromosomes, different from the other genome,
did not present alterations such as deletions or inversions,
thanks to the presence of a protective cap that himself
called «terminal gene» and afterwards «telomere», from
the greek terms «telos» (end) and «meros» (part)1.
Two years after, Barbara McClintock, respected
investigator from the University of Missouri (Columbia,
USA), who was dedicated to the study of corn genetics
(Zea mays), described how the rupture of the chromosomes
resulted in adhesion and fusion of their ends, with the
consequent formation of dicentric chromosomes. She
demonstrated that regardless of this damage, the ends
could be restored thanks to the acquisition of new telomere.
According to her conclusions, telomeres play a crucial role
in the integrity of the chromosomes, since they prevent the
appearance of «rupture-fusion-bridge» cycles which are
catastrophic for the cellular survival2.
The term «telomere» coined by Müller had apparently
a premonitory character, though everything pointed to an
immediate promissory future. The predominant skepticism
of that age in the genetic field made that research on the
importance of the ends of the chromosomes in replication
and integrity of the cell steeply stopped. It was only
reinitiated 30 years after, when the mechanisms subjacent
to the replication of the deoxyribonucleic acid (DNA)
were revealed, fact in which James Watson worked (the
same that described the double helicoidal structure of the
DNA). He identified the «problem of the terminal
replication» consisting on the incapacity of the cells to
completely replicate the linear ends of the DNA. Watson
postulated that, because of the special characteristics of
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the synthesis of the left behind chain of nucleic acid, which
cause that the DNA polymerase can not completely
replicate its end 3’, the telomere and therefore the
chromosomes were shortened. In addition he postulated
the existence of a protective mechanism to prevent the
chromosomal shortening3.
By the same age, Alexsei Matveevich Olovnikov, an
unknown russian scientist, found the link between the
problem of the end replication -named by Watson-, and the
cellular senescence at the same time described by Leonard
Hayflick. According to Hayflick (1961), senescence co-
rresponded to a status of detention of the proliferation to
which the human somatic cells entered with signs of
biochemical and morphologic alterations as a result of
having exceeded their replicative lifespan4.
For Olovnikov, the problem of the terminal replication
was the cause of the progressive shortening of the telomere
the one that as well, acted as an internal clock to determine
the number of divisions that the cell could experience
throughout its life and therefore to control the process of
aging5,6. The proposed model demonstrated to have an
impressive precision. At the present time, it is not only
accepted that the telomere shortening is the main cause of
the cellular senescence, but that it is actually the molecular
clock that counts the number of cycles that the cell can
support7.
Like James Watson, Aleksei Oloknikov believed that
the cell had a strategy to maintain its telomeric length
during the normal replication of the DNA. It did not take
long time to discover that such strategy had own name. It
was telomerase, reverse transcriptase enzyme in whose
discovery Elizabeth Blackburn, investigator from Tasmania,
played a crucial role.
Blackburn y Joseph Gall, famous biologists of the
University of Yale, initiated in 1975 their work with
Tetrahymena thermophila, ciliated protozoa that unlike
other eukaryotic organisms, has in addition of a micronucleus
with normal chromosomes, a macronucleus in which
fragmented chromosomes are found in multiple small
segments of DNA, having the same coding gene for
ribosomal RNA.
It was then possible to determine the sequence of the
extra-chromosomal DNA in whose ends they appeared
multiple repetitions of the hexanucleotid CCCCAA those
that also were found in the micronucleus8. Nevertheless
the finding brought with him doubts: it was perhaps a rare
property of an extra chromosomal gene pertaining to a
ciliated organism that in addition did not form part of the
main eukariota evolutive line? Or it was perhaps an
authentic telomeric sequence?
The question was without response until Blackburn
solved to be associated with Jack Szostak, molecular and
geneticist biologist of the Harvard Medical School, in a
certain joint venture that finally lead to the discovery of the
telomeric sequences and the enzyme that synthesizes
them. The work of Szostak, unfruitful until that moment,
consisted of constructing artificial chromosomes that
allowed cloning big groups of human genes in a yeast
single linear DNA molecule as a vector. The results were
discouraging, inasmuch as the chromosomes thus generated
were unstable and they did not replicate, due possibly to
the telomere deficiency. But when Szostak decided to
prove if the repetitive sequences discovered by Blackburn
and Gall could act like telomere in their experiment with
Saccharomyces cerevisiae, the results were forceful: the
yeast linear plasmids -assembled from the vector and of
the telomeric ends of the T. thermophila DNA- were
replicated in a stable way. Blackburn and Szostak
concluded that if the yeast was able to recognize and use
such ends pertaining to a so evolutionary distant organism,
this fact constituted reasonable evidence regarding the
high evolutionary conservation of the telomeric replication
mechanisms. This finding was linked to other not less
important: one when by means of maps of restriction and
tests of hybridization they analized the ends of T. thermopila
DNA as well as the yeast fragments that were supposed
to act as telomere, and it was found that the telomeric
sequences were common for both organisms9,10. On the
other hand, the replicated plasmids had a greater length,
understood if it were considered that the strategy of the
yeast cells perhaps consisted of adding new repetitive
sequences to the ends of the repetitive sequences of T.
thermophila. Thus, Blackburn and Szostak suggested
that the telomere elongation was due to the activity of an
unknown enzyme that synthesized telomere, later called
telomerase11.
Then Blackburn and Szostak had created not only the
first known functional test for telomere, but also laid the
foundations for the later construction of the first yeast
artificial chromosomes, the famous YACs12, used
afterwards in the development of the Human Genome
Project, for cloning great human DNA segments, that
could be sequenced later13,14. Without still counting on a
satisfactory explanation to clarify the true reason for
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which the replicated plasmids in their work with Szostak
had a greater length, Elizabeth Blackburn and her student
Carol Greider they later undertook years in the University
of California the memorable work that took them to
propose the existence of an enzymatic activity to which
they did not doubt in calling «telomere terminal transferase»,
same telomerase. They used extracts of cells of T.
thermophila and primers constituted per identical
sequences to the present ones in the telomere yeast and T.
thermophila cells. Their results demonstrated the synthesis
of novo of tandem TTGGGG repetitions, which were
added to the oligonucleotid primers, thanks to the activity
of the new enzyme described by them15.
The results obtained by Blackburn and her collaborators
marked a landmark in the investigation of the biology of the
telomere, because they explained the apparent contra-
diction between two verified facts: first, the progressive
shortening of the telomere during each cell division and
second, its replication, process that happens in independent
way to the one of the rest of the chromosomal DNA. While
the non-telomeric DNA uses for its replication the DNA
polymerase enzyme, the DNA of the telomere uses a
RNA template that adds new telomeric repetitions. This
forms an integral part of the telomerase molecule and it is
in fact the mold on which the copy of the telomere is
generated, in a process denominated reversed transcription.
In addition to RNA (TR) subunit, telomerase contains a
catalytic subunit (TERT). Absent or little expressed in the
somatic cells, telomerase is found in embryonic and
germinative cells (oogonia and spermatogonia), as well as
in most of transformed cells (immortalized cellular lines
and cancerous cells), where resists the problem of absence
of replication at the telomeric ends16,17.
 At the present time it is accepted that telomere length
and telomerase expression varies considerably with age
and cellular type, facts that justified their use as biomarkers
to evaluate history and replicative potential between tissues
and age groups. Thus, in most of these, it has been possible
to identify an approximated pattern of telomeric dynamics
and telomerase expression. On the matter, it is interesting
to highlight that in the genesis of certain pathologies like
Alzheimer’s disease, coronary disease and cancer, among
others16-22, the difference between biological age (predicted
based on the telomeric length) and chronological age plays
a key role. On the other hand, the expression of telomerase
has been associated through solid evidence with onco-
genesis and cellular immortalizations, powerful reasons to
propose it for diagnosis and as therapeutic target in the
cancer treatment23.
In normal cells, telomere shortening during cell division
acts as a tumor-suppressor mechanism that «forces» to
that the cells leave the cellular cycle and enter an irreversi-
ble state of senescence24, where they cease to divide and
finally die. However, in the process of malignant trans-
formation, the senescence is also an important risk fac-
tor25,26: It exists ample evidence that demonstrates that it
can be eluded by cell with short telomere that have begun
to express telomerase. In this case, «the fugitive» cell
acquires a new status, because it is transformed not only
into malignant, but in addition in immortal, thanks to the
stabilizing action that the enzyme exerts on telomere27. But
senescence is not only a state of that prevents the cellular
growth: it also involves changes in the expression of
certain genes and confers resistance to apoptosis25,28.
This explains why senescent cells can be accumulated
in tissues and contributes as much to the aging process,
and to the genesis of associated diseases as well. When
this happens, there are hyperplasic and pre-malign
pathological alterations which favor the theory that cancer
development is depending on age, due possibly to a sum of
multiple mutations29,30. Therefore, senescence exerts a
protective effect against cancer to early ages, whereas to
greater ages it promotes the typical phenotype of aging25.
It is not surprising that tumor-suppressor mechanisms like
telomeric shortening and therefore senescence, can stimulate
cancer development in the delayed stages of life. This
apparent paradox is the one that has taken in the last decade
to that many men and women of science deeply investigate
the telomere-telomerase pair, with the purpose of discovering
the until now hidden key of immortality or well to reveal the
secret of the malignity that so jealously keeps.
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